Best hospitals for liver disease: An evidence-based guide to specialist and transplant care
How hospitals for liver disease are evaluated
There is no single universal ranking for the best hospitals for liver disease. Appropriate evaluation depends on whether a patient needs diagnosis, treatment for hepatitis or fatty liver disease, cirrhosis management, liver-cancer care, or transplantation. Relevant indicators include specialist depth, multidisciplinary coordination, transplant volume, published outcomes, access to clinical trials, and experience with complex cases. U.S. News & World Report uses measures including survival, patient experience, and nurse staffing in its hospital assessments, while transplant performance is tracked through national reporting systems.
The American Liver Foundation maintains a directory of transplant centers across the United States, organized by state and including reported transplant totals. Its listings show substantial variation in activity, from small pediatric programs to large academic centers. A center's volume can provide useful context, but it does not independently establish that one hospital is appropriate for every patient. Diagnosis, insurance networks, geography, caregiver support, and the specific disease remain important parts of the evaluation.
- Confirm whether the hospital treats the relevant liver condition.
- Ask whether hepatology, surgery, oncology, radiology, and pathology coordinate care.
- Review transplant outcomes and waiting-list performance through current official data.
Mayo Clinic and complex liver care
Mayo Clinic operates a three-site liver transplant program in Arizona, Florida, and Minnesota, described by the institution as one of the largest and most experienced in the country. Its teams report work involving bioartificial livers, biliary stem cells, and trials evaluating anti-rejection medicines. The program also lists specialized expertise in living-donor transplantation, multiorgan procedures, pediatric transplantation, hepatitis C-positive recipients, immune-mediated liver disease, obesity-related NASH, and hilar cholangiocarcinoma.
Mayo's cirrhosis program uses a multidisciplinary model involving 13 specialty groups and more than 140 digestive disease specialists. The institution reports that nearly 8,000 people with cirrhosis are treated there annually and identifies magnetic resonance elastography as a diagnostic technology pioneered by Mayo researchers. Mayo also states that its surgeons have performed thousands of liver transplants and that its program has one of the country's strongest long-term survival records. These statements are institutional descriptions, not a guarantee of an individual outcome.
Montefiore Einstein and transplant specialization
Montefiore Einstein describes its liver transplantation program as serving children and adults with acute or chronic liver disease and liver cancer. Its model combines pediatric and adult transplant specialists with advanced diagnostic imaging for donor and recipient evaluation. The program reports expertise in complex pediatric cases, including transplantation in infants younger than one year, and in multiorgan procedures such as heart-liver and kidney-liver transplantation.
Montefiore Einstein reports a 100% three-year survival rate among pediatric and adult recipients of living-donor liver transplants in the figures presented on its website. It also states that adult deceased-donor recipients had a three-year survival rate described as the highest in New York State, exceeding national standards. The same page reports 100% one-year survival among adult liver-heart transplant recipients and pediatric kidney-liver recipients. Outcome statistics require careful interpretation because results depend on patient selection, case complexity, sample size, and reporting period.
Penn Medicine's multidisciplinary services
Penn Medicine provides specialist care for hepatitis, cirrhosis, fatty liver disease, and other liver disorders, with gastroenterology and transplant surgery teams working alongside radiology, pathology, and related departments. Its program describes the region's largest liver transplant and living-donor programs. This structure is relevant for patients whose needs change over time, such as those requiring repeated imaging, medication management, cancer assessment, or consideration of transplantation.
Penn identifies several focused services within its liver program. The Liver Tumor Clinic coordinates evaluation for transplantation, surgical removal, regional interventions, systemic therapy, or combinations of these treatments. Its Ascites Clinic addresses difficult-to-control abdominal fluid and includes access to an automated fluid-pumping device. The iLEARN Clinic provides multidisciplinary management for alcohol-related liver disease, with an emphasis on improving transplant opportunities and outcomes. These specialized clinics illustrate why service fit may matter more than a general hospital ranking.
IU Health, OU Health, and regional access
IU Health reports providing liver disease management and transplant services for adults and children with acute or chronic liver failure, primary liver malignancies, and metabolic or genetic disorders. The program states that it performed 215 liver transplants in 2024, including 204 adult and 11 pediatric procedures, and that this combined volume was the fifth highest in the United States. It also describes a living-liver donation team and a process for reviewing donor organs that other centers may have declined.
OU Health describes its transplant institute as handling complex liver transplant cases, including patients with multiple health problems or rare diagnoses. It reports the shortest median waiting time for a liver transplant in Oklahoma according to Scientific Registry of Transplant Recipients statistics. Waiting time can affect clinical decisions, but it should be considered with survival, organ quality, patient eligibility, distance from the center, and the ability to meet follow-up requirements. Regional programs may reduce travel burdens while still providing advanced specialty services.
UC Davis and National Jewish Health
UC Davis Health reported that recent Scientific Registry of Transplant Recipients data showed liver transplant patients outperforming national expectations and averages for transplanted-organ survival. The report also described better survival while waiting and faster access to transplantation than national benchmarks. UC Davis stated that its program performed 59 liver transplants in 2025, including 58 deceased-donor procedures and one living-donor procedure, and anticipated approximately 70 transplants in 2026.
National Jewish Health in Denver approaches liver disease primarily through diagnosis, treatment, monitoring, and prevention of complications. Its program lists fellowship-trained, board-certified liver specialists, nutritional counseling, cancer screening, FibroScan, CT, MRI, and MRI elastography. The institution reports that thousands of adults receive care through the program each year. This type of hepatology-focused service may be relevant for patients who do not need transplantation but require accurate staging, long-term monitoring, or management of lifestyle-related and metabolic factors.
Practical risks and questions before choosing a center
Liver transplantation is not a routine procedure and requires formal assessment of medical eligibility, disease severity, organ availability, psychological and social support, medication adherence, and the ability to attend continuing follow-up. Living donation introduces separate considerations for the donor, including evaluation and surgical risk. After transplantation, recipients generally require ongoing anti-rejection treatment and surveillance. The presence of a prestigious name or high procedure count cannot remove risks such as infection, graft failure, complications, recurrence of disease, or death.
Patients comparing hospitals should request current, center-specific information rather than relying solely on promotional language or an old ranking. Useful questions include how outcomes are reported, how many procedures were performed in the relevant period, whether results are risk-adjusted, how long evaluation takes, and which services are available locally after discharge. Official transplant data, specialist consultation, and a second clinical opinion can help place hospital claims in context. Eligibility and treatment decisions must be determined by qualified clinicians.
- Identify the disease stage and the immediate clinical objective.
- Separate general hepatology care from transplant evaluation.
- Compare survival, waiting-list outcomes, volume, and follow-up requirements.
- Consider travel, caregiver arrangements, costs, and continuity of care.
Sources
- Mayo Clinic, Liver Transplant: Expertise and rankings
- Montefiore Einstein, Liver Disease & Transplant Care
- American Liver Foundation, Find a Liver Transplant Center
- Penn Medicine, Liver Disease Care
- Mayo Clinic, Cirrhosis Care
- IU Health, Liver Transplant
- OU Health, Liver Transplant Services
- UC Davis Health, National data on liver transplant programs
- National Jewish Health, Liver Disease Program
Authored by 24Trendz team